Mark Hofmeyer, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience
J Card Fail
2021 Sep;27(9):974-980. doi: 10.1016/j.cardfail.2021.06.006
Date: 09 2021
https://www.onlinejcf.com/article/S1071-9164(21)00242-6/fulltext

Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy
JAMA
2022 Feb 1;327(5):454-463. doi: 10.1001/jama.2021.24674
Date: 02 2022
https://jamanetwork.com/journals/jama/fullarticle/2788528

Outcomes in patients with smaller body surface area after HeartMate 3 left ventricular assist device implantation
Artif Organs
2022 Mar;46(3):460-470. doi: 10.1111/aor.14065
Date: 03 2022
https://onlinelibrary.wiley.com/doi/full/10.1111/aor.14065

The impact of left ventricular size on outcomes after centrifugal-flow left ventricular assist device implantation
Eur J Cardiothorac Surg
2022 Jun 15;62(1):ezab480. doi: 10.1093/ejcts/ezab480
Date: 06 2022
https://academic.oup.com/ejcts/article-abstract/62/1/ezab480/6425613?redirectedFrom=fulltext&login=t

Beta-blockers and Ambulatory Inotropic Therapy
J Card Fail
2022 Aug;28(8):1309-1317. doi: 10.1016/j.cardfail.2022.03.352
Date: 08 2022
https://www.onlinejcf.com/article/S1071-9164(22)00486-9/fulltext

Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated Cardiomyopathy.
JAMA Cardiol
2023 Jan 1;8(1):33-42. doi: 10.1001/jamacardio.2022.4132.
Date: 01 2023
https://jamanetwork.com/journals/jamacardiology/article-abstract/2798648